F10 & F9 activated form, Human (Emicizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-F10 & F9 activated form, Human (Emicizumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityF10 & F9 activated form, Human (Emicizumab biosimilar)
CloneEmicizumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG4 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human F10 & F9 activated form Recombinant Antibody. Emicizumab (trade name Hemlibra) is a humanized bispecific antibody for the treatment of haemophilia A, developed by Genentech and Chugai (a subsidiary of Roche). A Phase I clinical trial found that it was well tolerated by healthy subjects.
Immunogenn/a
Other NamesAnti-F10 & F9 activated form Recombinant Antibody, Research Grade Emicizumab, Anti-Human F10 & F9 activated form Recombinant Antibody, ACE-910, RG6013, hBS910, Antibody Drug Analogues, Monoclonal Antibody, YR1383, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1610943-06-0
Catalog #YR1383
Priceplease inquire
Order / More InfoF10 & F9 activated form, Human (Emicizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.